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EVALUATION OF YORTACAVAL SHUNT PATENCY WITH 
THE DIFFERENTIAL GLUCOSE TOLERANCE TEST 
GILBERT HERMANN, M.D., THOMAS A. WITTEN, M.D., and 
THOMAS E. STARZL, M.D., Ph.D., F.A.C.S., Denver, Colorado 
IN THE MANAGEMENT of patients in whom 
surgical portal-systemic shunts have been 
established, it may be important to know 
the state of patency of the anastomosis. Such 
information would always be of prognostic 
significance postoperatively. If recurrent 
hemorrhage occurs after the shunting pro- 
cedure, this knowledge would be of utmost 
value in planning the therapy, since the 
bleeding could be either secondary to 
thrombosis of the anastomosis or be attrib- 
utable to any of the other causes of upper 
gastrointestinal bleeding. Finally, it would 
permit a more objective evaluation of the 
operative results as compared with the re- 
sults of nonoperative care, since technical 
failures could readily be detected. In the 
past, considerable effort has been expended 
to develop methods of detecting the patency 
of the shunt. The techniques have been 
limited by their inherent dangers or be- 
cause complex technical or biochemical 
procedures were required. 
An evaluation of a differential glucose 
technique for determining shunt patency is 
herein presented. In principle, it involves 
the ingestion of a glucose meal, following 
which the plasma glucose content is meas- 
ured in samples obtained simultaneously 
from a peripheral systemic vein and from 
the inferior vena cava at, or just above, the 
anastomotic site. The method requires no 
special equipment or analytic determina- 
tions. In the case of a patent shunt, the vena 
caval sample which is mixed with portal 
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blood would be expected to have a signifi- 
cantly higher plasma glucose content than 
a simultaneous peripheral venous sample. 
In a series of cirrhotic patients not oper- 
ated upon who had portal hypertension 
differential glucose studies were carried out 
for comparison with results obtained from 
patients having had a portal-systemic anas- 
tomosis. Because it is frequently impossible 
to obtain anatomic verification of shunt 
patency in human beings, a companion 
series of dogs was prepared, and differential 
glucose studies carried out before and after 
the performance of Eck fistulas. Complete 
autopsy information on shunt patency was 
available in the latter series. 
METHOD 
Laboratory. Trained, fasted mongrel dogs 
of both sexes, weighing between 10 and 20 
kilograms, were used. Under local anes- 
thesia, a catheter was inserted into the 
inferior vena cava of each dog by way of a 
small branch of the femoral vein. After 
injection of 10 cubic ' centimeters of 50 per 
cent hypaque sodium, to allow pyelographic 
visualization of the kidneys, the catheter 
was positioned so that its tip would be 
opposite the twelfth thoracic to first lumbar 
interspace. This site usually coincided with 
the upper half of the left kidney. A second 
catheter was inserted into the external 
jugular vein. After withdrawal of 3 pairs of 
control samples, 50 grams of glucose were 
administered through a stomach tube, and 
simultaneous blood samples were obtained 
from each catheter at 15 minute intervals 
for 2 hours. Plasma glucose determinations 
were carried out with an autoanalyzer. 
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FIG. 1. Technique of sampling for differential glucose 
tolerance test in human beings. The inferior vena caval 
catheter is inserted percutaneously to, or just above, the 
anastomotic site. Peripheral venous samples are obtained 
from a vein of the arm. Samples from the 2 sites are 
drawn simultaneously, before and after a glucose meal. 
The following day, Eck fistulas were 
created by fashioning a side-to-side porta- 
caval anastomosis cephalad to the renal 
veins. The portal vein was ligated between 
the anastomosis and the liver. Silver clips 
were placed around the anastomotic site for 
future roentgenographic identification. 
Approximately 10 days postoperatively, 
a second glucose tolerance test was carried 
out, each dog, thus, serving as his own 
control. The tip of the inferior vena caval 
catheter was positioned just cephalad to the 
most superior silver clip. Upon completion 
of the test, an autopsy was performed upon 
each dog to ascertain the patency of the 
shunt. All shunts were found to be widely 
open. There were 9 dogs in the preshunt and 
8 in the postshunt group, 1 dog having died 
postoperatively. 
Clinical. The patients were in a fasting 
state at  the time of the examination. A 
percutaneous puncture of the femoral vein 
was performed with a No. 13 short bevel 
needle. A No. 160 polyethylene catheter was 
inserted into the inferior vena cava through 
the needle (Fig. 1). The needle was then 
withdrawn and the catheter flushed with a 
heparin saline solution. Twenty cubic centi- 
meters of 50 per cent hypaque sodium were 
injected into the catheter, and the tip was 
positioned postoperatively between the 
twelfth thoracic and first lumbar vertebrae 
or just cephalad to the level of the silver 
clips. The opacification of the kidneys was 
often a help in correctly positioning the 
catheter. A similar indwelling catheter was 
introduced into a vein of the upper ex- 
tremity (Fig. 1) to obviate the necessity of 
multiple venipunctures. Two control sam- 
ples were taken. Then 100 grams of glucose 
were given orally, and simultaneous blood 
samples of 3 cubic centimeters were with- 
drawn from each catheter every 10 minutes 
for a period of 1 hour. 
RESULTS 
Normal dogs. Nine normal dogs were 
studied. The mean plasma glucose in the 
jugular control samples was 104 f 1.6 (S.E., 
standard error) milligrams per 100 cubic 
centimeters. After oral ingestion of glucose, 
glucose concentration in the jugular samples 
rose to a maximum of 1801k15.8 (S.E.) 
milligrams per 100 cubic centimeters after 
60 minutes and then declined. 
In the control period the plasma glucose 
concentration in the inferior vena caval 
samples was 105 f 1.3 (S.E.) milligrams per 
100 cubic centimeters. After glucose inges- 
tion it rose to 188 f 16.6 (S.E.) milligrams 
per 100 cubic centimeters after 60 minutes. 
The glucose concentration differences 
between the inferior vena caval sample, 
hereinafter designated I, and the jugular 
sample, hereinafter designated P to indicate 
its peripheral origin, were not significantly 
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different during the control period (Fig. 2). 
The I-P difference was 0.4 + .4 (S.E.) mil- 
ligrams per 100 cubic centimeters. After 
glucose ingestion the I-P difference in- 
creased to a maximum of 12 +2.6 (S.E.) 
milligrams per 100 cubic centimeters at  60 
minutes and then slowly declined (Fig. 2). 
Dogs with Eck Ji.itu1a.i. Eight dogs were 
studied, and the mean fasting plasma glu- 
cose in the jugular samples was 102 k2.1 
(S.E.) milligrams per 100 cubic centimeters. 
After the glucose meal, glucose concentra- 
tion in the jugular sample rose to a maxi- 
mum of 293 f 15.8 (S.E.) milligrams per 100 
cubic centimeters after 60 minutes. 
Fasting plasma glucose control values in 
the inferior vena cava were 103-t2.6 
(S.E.) milligrams per 100 cubic centimeters. 
After glucose ingestion, these values rose to 
a maximum of 330 f 19.1 (S.E.) milligrams 
per 100 cubic centimeters after 60 minutes. 
The I-P plasma glucose concentrated 
difference was 1 f .8 (S.E.) milligrams per 
100 cubic centimeters in the control period. 
After glucose ingestion, the I-P difference 
increased immediately to a maximum of 
34.5 A 8.4 (S.E.) milligrams per 100 cubic 
centimeters after 15 minutes. The increase 
in I-P difference was sustained for at least 
120 minutes (Fig. 2). 
Patients with cirrhosis. The 5 patients in 
this group all had advanced cirrhosis, 
proved by liver biopsy with confirmatory 
liver function tests. The presence of portal 
hypertension was proved by demonstrating 
esophageal varices with esophagrams or 
esophagoscopy or by determination of 
elevated hepatic vein wedge pressures. 
Mean fasting plasma glucose in the 
control period was 90f3.7 (S.E.) milli- 
grams per 100 cubic centimeters in the 
samples taken from the veins of the arms. 
After oral ingestion of glucose, the maxi- 
mum hyperglycemic response was to 180 + 
14.4 (S.E.) milligrams per 100 cubic centi- 
meters after 60 minutes. 
The fasting plasma glucose level in the 
inferior vena caval samples was 92f 3.6 
(S.E.) milligrams per 100 cubic centimeters. 
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FIG. 2. Concentration differences of plasma glucose 
between the suprarenal inferior vena cava and the jugu- 
lar vein in dogs before and after a glucose meal. The line 
graphs represent mean values, and the vertical cross bars 
are the standard errors. The lower curve represents nor- 
mal dogs and the upper curve the same group of dogs 
after performance of Eck fistulas. "I" refers to inferior 
vena cava samples and "P" to the peripheral, jugular, 
sample. 
After glucose ingestion, this rose to 178 + 15 
(S.E.) milligrams per 100 cubic centimeters 
after 60 minutes. 
The I-P plasma glucose concentrating 
difference was 2.8 f .54 (S.E.) milligrams 
per 100 cubic centimeters in the control 
period. After oral ingestion of glucose, the 
I-P difference increased to a maximum of 
7.2 k2.5 (S.E.) milligrams per 100 cubic 
centimeters after 10 minutes (Fig. 3). 
Patients with cirrhosis after portal-systemic 
shunt. Six of the 7 patients in this group had 
either end-to-side or side-to-side portacaval 
shunts, and the seventh patient had a 
splenorenal shunt. Cirrhosis and preopera- 
tive portal hypertension were proved in all. 
On the basis of radiographic, esophago- 
scopic, and clinical grounds, the anastomoses 
were thought to be patent in all 7 patients. 
One patient was studied both before and 
after operation. Several months after the 
study was begun a second patient died 
following operation for intestinal obstruc- 
tion. At autopsy, the end-to-side portacaval 
anastomosis was found to be widely patent. 
Mean fasting plasma glucose from the 
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arm was 90 + 2.5 (S.E.) milligrams per 100 
cubic centimeters in the control period. 
After orally ingested glucose, the maximum 
hyperglycemia was 176+26 (S.E.) milli- 
grams per 100 cubic centimeters after 40 
minutes. 
In  the inferior vena cava, control plasma 
glucose was 71 + 2.2 (S.E.) milligrams per 
100 cubic centimeters. After orally ingested 
glucose, this figure rose to a maximum of 
207 $- 33 (S.E.) milligrams per 100 cubic 
centimeters in 40 minutes. 
The mean control I-P plasma glucose 
difference was 2.8k.76 milligrams per 100 
cubic centimeters. After oral ingestion of 
glucose, the I-P concentration difference 
was sharply increased for the entire test 
period (Fig. 3) to a maximum of 31 f 6.3 
(S.E.) milligrams per 100 cubic centimeters 
after 20 minutes. There was no overlap in 
the maximum I-P difference in those not 
operated upon as compared to those having 
surgical portal systemic shunts. The highest 
I-P glucose difference ever observed in a 
patient in whom a shunt was not established 
was 14 milligrams per 100 cubic centimeters. 
The lowest I-P difference observed in a pa- 
tient having a shunt was 16 milligrams per 
100 cubic centimeters. This value was ob- 
tained in the only patient in this series who 
h a c k  splenorenal shunt. The lowest maxi- 
mum I-P difference in the patients with 
portacaval anastomoses was 20 milligrams 
per 100 cubic centimeters. 
In  1 patient, glucose studies performed 
before and after operation were particularly 
helpful because of the complicated nature 
of the operative procedure. 
REPORTS OF PATIENTS 
PATIENT 1. A 36 year old male was admitted to the 
hospital for treatment of recurrent ascites and upper 
intestinal hemorrhage. Examination revealed esoph- 
ageal varices and advanced liver disease. Preoperative 
hepatic vein wedge pressure was 31 millimeters of 
mercury. A side-to-side portacaval shunt was per- 
formed on 25 June 1962. The operative procedure was 
complicated by the necessity of performing a throm- 
bectomy in the portal vein to remove old and recent 
thrombi. A satisfactory anastomosis was obtained with 
good flow and satisfactory pressure drop in the 
splanchnic system. The postoperative course was 
benign. Differential glucose studirs wrre performed 2 
weeks postoperatively. Inasmuch as the maximum 
I-P plasma glucose conccntration differential rose to 
42 milligrams per 100 cubic ccntimcters postopera- 
tively as compared to 14 milligrams per 100 cubic 
centimeters preoperative1 y, it was believed that the 
shunt was widely patent. 
In another patient admitted for evalua- 
tion of her hepatic status, glucose studies 
were invaluable in assessing shunt patency. 
PATIENT 2. This 58 yrar old. alcoholic female had 
had an end-to-side portacaval shunt in 1957. She 
was readmitted to the hospital in April 1962 because 
of jaundice and lethargy. Studies revealed advanced 
liver disease. A barium swallow was interpreted as 
demonstrating esophageal varices. 
A differential glucose tolerance test was performed. 
This revealed a maximum I-Pconcentration difference 
of 64 milligrams of glucose per 100 cubic centimeters 
of plasma. Therefore, despite the roentgenographic 
finding of esophageal varices, the test indicated that 
the previously constructed shunt was still functioning. 
The patient died 3 months after readmission from 
unrelated causes. The portacaval anastomosis was 
found to be widely patent at  autopsy. 
DISCUSSION 
A number of techniques have been 
evaluated for determining anastomotic pa- 
tency after a portal-systemic shunt. MOST 
investigators have attempted to establish a 
method which is applicable to all patients, 
gives consistent results, is simple to perform, 
is easy to interpret, and affords a minimal 
risk. 
The most direct approach has been to 
enter the portal system in order to measure 
the pressure. Atkinson and his associates 
have recommended postoperative splenic 
puncture. Palmer has described needle 
puncture of esophageal veins through an 
esophagoscope. Collapse of the varices 
after successful decompression makes the 
latter method impractical. In addition, 
fatal hemorrhage from a torn varix has been 
reported by Deterling and his associates 
following this procedure. Attempts have 
also been made to enter the portal vein by 
retrograde catheterization through porta- 
caval anastomoses. Dotter and his associates 
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reported upon 1 case, while Warren and 
Thomphon catheterized the portal vein via 
the patent anastomoses in 7 patients. While 
useful as an investigative tool, the technical 
difficulties involved probably preclude the 
widespread acceptance of this method. It 
is obvious that failure to enter the portal 
vein is not proof that the anastomosis has 
closed. 
There have been many reports of at- 
tempts at  direct visualization of the anasto- 
mosis with the rapid injection of radiopaque 
dyes directly into the portal circulation. 
Splenoportography has become an accepted 
diagnostic tool, both in the preoperative, as 
well as postoperative, evaluation of the 
splanchnic venous circulation. This method 
suffers from the slight, but definite, danger 
involved in splenic puncture, the inability 
to carry out the examination in the absence 
of the spleen, as in a postoperative spleno- 
renal shunt, and lastly, the need for special- 
ized technical help. Giuseffi and Largen 
have described a method utilizing a double 
balloon tube to "trap" the area of the 
anastomosis while the dye is being injected 
for roentgenographic visualization of the 
areas. 
A different approach to this problem has 
been the measurement of decreased portal 
circulation time which exists in patients 
with patent shunts. Many of these methods 
require injection into the splenic pulp of a 
substance which can be readily detected 
when it reaches the systemic circulation. 
Gilsanz and his associates have employed 
ether, and Morrow (14) has used indocya- 
nine green and radioactive krypton. In 
other studies, rectal veins have been used to 
gain entry into the splanchnic system. 
Ether has been extensively evaluated by 
Newman and later by Giges and Teschan 
but Waldstein and his associates have found 
it to be unreliable due to the vague end 
point. Deterling and his associates have in- 
stilled radioactive sodium into the rectum 
and measured the time of its appearance in 
the brachial artery by means of an external 
scintillation counter. There was wide varia- 
FIG. 3. Concentration differences of plasma glucose 
between the suprarenal inferior vena cava ( I )  and the 
arm veins (P) of cirrhotic patients before and after 
ingestion of 100 grams of glucose orally. Points are mean 
values and the vertical cross bars standard errors. The 
lower curve represents cirrhotic patients who were not 
operatrd upon. The upper curve represents cirrhotic 
patients in whom a portacaval or splenorenal shunt had 
been established. 
tioii in normal or cirrhotic patients, but in 
all postoperative patients with patent shunts 
the circulation times were short. This 
method, although apparently possessing 
validity, necessitates a preoperative and 
postoperative examination as well as com- 
plex equipment. 
Other methods have been described 
which are based upon the inability of the 
bypassed liver to metabolize test substances 
rapidly. Eiseman and his associates (8, 9) 
have employed oral ingestion of ammonium 
salts and Akita and his associates (1, 2) 
have used bile salts as the test drug. These 
techniques, besides requiring special labo- 
ratory skills, suffer from the fact that a 
severely impaired liver detoxifies test sub- 
stances so slowly as to mimic the curve 
obtained in instances of a patent shunt. In 
addition, Levine and Rigler found in evalu- 
ating the ammonium tolerance test, that 
2% months after closure of a portacaval 
shunt in dogs, extensively developed col- 
laterals caused false peripheral elevation. 
The difference in postprandial plasma 
glucose concentration between a peripheral 
vein and one draining the splanchnic bed 
has been previously described. In 1946, 
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Sherlock and Walshe noted that a large 
glucose concentration difference was present 
after a test meal between the samples drawn 
from abdominal wall venous collaterals and 
the veins of the upper extremity. A similar 
study by Billings and DePree confirmed 
these findings. Subsequently, Allard and his 
associates reported a case in which the left 
renal vein was catheterized after splenorenal 
shunt. Simultaneous blood samples, taken 
from this site as well as a peripheral vein, 
revealed a difference in glucose concen- 
tration. 
In  our experience, the differential glucose 
tolerance test has proved to be a valuable 
method for assessing anastornotic patency. 
The reliability of the method depends upon 
the observance of a few details of both 
technique and interpretation. Proper place- 
ment of the vena caval catheter is the most 
important of these. If the catheter is too 
low, the disproportionate rise in plasma 
glucose in the vena caval samples will not 
be observed. If it is too high, the samples will 
be contaminated with blood from the 
glucose-rich hepatic veins. These errors are 
readily avoided, using the renal shadows, 
the vertebrae, or silver clip tagged anasto- 
mosis as a landmark. 
The ideal application of this test would 
be in cases in which the preoperative de- 
terminations could be compared with those 
obtained after operation. In normal dogs, 
as well as nonshunted cirrhotic human 
beings, a small increase in the vena caval- 
peripheral vein concentration difference is 
observed after a glucose meal, presumably 
due to small splanchnic-vena caval com- 
munications. However, in patients who 
have not been studied preoperatively, it is 
still possible to obtain accurate data on the 
patency of the shunt. If the maximum 
glucose concentration difference is less than 
12 milligrams per 100 cubic centimeters, it 
is very unlikely that the anastomosis is open 
and effectively decompressing the splanch- 
nic bed. If the maximum difference exceeds 
20 milligrams per 100 cubic centimeters, 
shunt patency is virtually assured. In this 
study, all patients with portacaval shunts 
exhibited a glucose concentration difference 
exceeding 20 milligrams per 100 cubic 
centimeters. The single patient with a 
- A 
splenorenal anastomosis had a maximum 
glucose difference of 16 milligrams per 100 
cubic centimeters. In these smaller-shunts, 
therefore, the method may provide less 
accuracy. 
SUMMARY 
A method has been described for estab- 
lishing shunt patency by determining the 
difference in postprandial plasma glucose 
levels between a peripheral vein and the 
inferior vena cava at or near the site of the 
portal-systemic anastomosis. This test was 
evaluated both in the laboratory with 
normal dogs before and after ~ c k '  fistula 
u 
formation as well as in cirrhotic patients 
with and without shunts. 
The results indicate that this test is 
reliable and has the advantages of safety, 
specificity, and ease of performance. 
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